Study to Evaluate Optimized Retreatment and Prolonged Therapy With Bortezomib
Clinical trial NCT01910987 · COMPLETED
Trial details
- NCT number
- NCT01910987
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-02-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.